Skip to main content

Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease

Publication ,  Journal Article
McCrory, DC; Brown, CD
Published in: Evidence-Based Medicine
May 1, 2003

Duke Scholars

Published In

Evidence-Based Medicine

DOI

ISSN

1356-5524

Publication Date

May 1, 2003

Volume

8

Issue

3

Start / End Page

74

Related Subject Headings

  • General & Internal Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McCrory, D. C., & Brown, C. D. (2003). Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine, 8(3), 74. https://doi.org/10.1136/ebm.8.3.74
McCrory, D. C., and C. D. Brown. “Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease.” Evidence-Based Medicine 8, no. 3 (May 1, 2003): 74. https://doi.org/10.1136/ebm.8.3.74.
McCrory, D. C., and C. D. Brown. “Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease.” Evidence-Based Medicine, vol. 8, no. 3, May 2003, p. 74. Scopus, doi:10.1136/ebm.8.3.74.

Published In

Evidence-Based Medicine

DOI

ISSN

1356-5524

Publication Date

May 1, 2003

Volume

8

Issue

3

Start / End Page

74

Related Subject Headings

  • General & Internal Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences